Načítá se...
Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples
BACKGROUND: Hepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence immunoassay (CLIA) became available. STUDY DESIGN...
Uloženo v:
| Vydáno v: | Transfusion |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744653/ https://ncbi.nlm.nih.gov/pubmed/26013970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.13179 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|